EndoQuest raises funding for endoluminal robotics technology
The company is developing endoluminal interventions for therapeutic endoscopists and surgeons to carry out upper and lower gastrointestinal surgery. Credit: MAD.vertise / Shutterstock.com. Medical device company EndoQuest Robotics has secured $42m in a C-1 preferred financing round for advancing its endoluminal robotics technology. The robotic system offers flexibility and precision, along with improved patient outcomes. […]
Telix doses first subject in kidney cancer imaging agent study
The programme is evaluating an investigational PET imaging agent for clear cell renal cell carcinoma. Credit: Magic mine/Shutterstock.com. Telix Pharmaceuticals has dosed the first subject in a European named patient (early access) programme for kidney cancer imaging agent, TLX250-CDx (⁸⁹Zr-DFO-girentuximab). The programme in the Netherlands is evaluating the investigational positron emission tomography (PET) imaging agent […]
Game changing: How AI and automation is revolutionising clinical trial admin
In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned from the pandemic years, it is that effective development and testing of drugs and vaccines can have a tremendous impact. The success of such developments, however, hinges on even the smallest factors. This is why […]
Experts say femtech funding booming despite wider investment downturn
Panellists were discussing the future of femtech at the ongoing GIANT Health conference being held in London during 4-5 December. Image credit: Robert Barrie/GlobalData. The femtech sector is going from strength to strength, despite the weaker investment landscape throughout the healthcare industry, experts say. Panellists were discussing the future of femtech at the ongoing GIANT […]
Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug
AstraZeneca, a leading pharmaceuticals company, has signed a deal with US biopharma Absci. Photo: Mikael Sjoberg/Bloomberg via Getty Images. Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech AbSci Corporation to develop an antibody therapy for an undisclosed cancer using Absci’s AI technology. The deal, signed yesterday (3 November), is worth up to […]
Q+A: Roche’s Nicole Arming and Stefano Volonté on personalised medicine’s potential
Understanding the genetic framework in an individual living with a disease gives clinicians a holistic picture needed to provide the optimal path for prevention, diagnosis, or treatment of a disease. Image credit: Shutterstock/DrAfter123. Personalised medicine is generating significant interest in the healthcare industry as standard blanket approaches to patient therapies metamorphose into individualised treatment plans. […]
Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study
Smoking tobacco is responsible for approximately 480,000 deaths each year in the US and can cause numerous health conditions such as cancer, heart disease and strokesCredit: Shutterstock/chayanuphol Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery platform, QN-01, is under evaluation in the […]
Robot glove for stroke patients receives £435k boost from Innovate UK
The device is set to undergo a trial set to launch in the US at the start of next year. Credit: Bioliberty An Edinburgh start-up, based out of the National Robotarium, has been awarded £435,000 ($570,000) to accelerate its robotic glove aimed at assisting stroke patients to the market. Bioliberty received the money from the […]
Colibri’s valve shows superior haemodynamics in pilot study
The pilot study has demonstrated superior haemodynamics of Colibri’s ready-to-use balloon-expanded valve. Credit: mi_viri / Shutterstock.com. Colibri Heart Valve announced that the transcatheter aortic valve (TAVR) pilot study in the European Union (EU) has shown superior haemodynamics of its ready-to-use balloon-expanded valve. The Centre Européen de Recherche Cardiovasculaire (CERC) conducted the study in the role […]
SCARS Center selects SciBase’s Nevisense to detect skin cancer
Nevisense is claimed to be the only device approved by the US FDA to detect melanoma. Credit: Ocskay Mark / Shutterstock.com. The Skin and Cancer Reconstructive Surgery Center (SCARS Center) in California, US, has selected SciBase Holding’s Nevisense system for the detection of skin cancer early. This collaboration aims to expand the presence of Nevisense […]